📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Below are the financial statements of Eli Lilly and Co, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
Below are the financial statements of Eli Lilly and Co, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 45.04a | 34.12a | 28.54a |
| Costs, expenses, and other | — | — | — |
| Cost of sales | -8.42a | -7.08a | -6.63a |
| Research and development | -10.99a | -9.31a | -7.19a |
| Marketing, selling, and administrative | -8.59a | -7.4a | -6.44a |
| Acquired in-process research and development | -3.28a | -3.8a | -0.91a |
| Asset impairment, restructuring, and other special charges | -0.86a | -0.07a | -0.24a |
| Other - net, (income) expense | 0.22a | -0.1a | 0.32a |
| Income before income taxes | 12.68a | 6.55a | 6.81a |
| Income taxes | -2.09a | -1.31a | -0.56a |
| Net income | 10.59a | 5.24a | 6.24a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Eli Lilly and Co’s data sources below and access millions more through our Disclosure Search.